Edgestream Partners L.P. Raises Stock Holdings in National Health Investors, Inc. $NHI

Edgestream Partners L.P. increased its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 139.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,425 shares of the real estate investment trust’s stock after purchasing an additional 21,813 shares during the quarter. Edgestream Partners L.P. owned approximately 0.08% of National Health Investors worth $2,624,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in NHI. JPMorgan Chase & Co. boosted its stake in shares of National Health Investors by 305.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock worth $84,389,000 after purchasing an additional 906,479 shares during the last quarter. Norges Bank acquired a new position in shares of National Health Investors in the second quarter valued at approximately $49,775,000. MetLife Investment Management LLC lifted its stake in shares of National Health Investors by 706.6% during the first quarter. MetLife Investment Management LLC now owns 213,730 shares of the real estate investment trust’s stock valued at $15,786,000 after buying an additional 187,233 shares during the period. Bowen Hanes & Co. Inc. acquired a new stake in National Health Investors during the first quarter worth approximately $10,340,000. Finally, Nuveen LLC purchased a new stake in National Health Investors in the 1st quarter worth approximately $10,126,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Price Performance

NHI stock opened at $78.96 on Friday. The stock has a 50-day moving average price of $76.68 and a two-hundred day moving average price of $74.74. National Health Investors, Inc. has a 12-month low of $65.13 and a 12-month high of $80.56. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74. The company has a market cap of $3.76 billion, a PE ratio of 24.91, a price-to-earnings-growth ratio of 3.05 and a beta of 0.68.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.08. The company had revenue of $83.36 million for the quarter, compared to the consensus estimate of $85.66 million. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The company’s quarterly revenue was down 1.8% compared to the same quarter last year. During the same period last year, the business posted $1.03 EPS. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. As a group, research analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be paid a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 4.7%. The ex-dividend date is Wednesday, December 31st. National Health Investors’s payout ratio is currently 116.09%.

Wall Street Analysts Forecast Growth

NHI has been the topic of a number of recent analyst reports. National Bankshares set a $90.00 price target on National Health Investors in a research note on Wednesday, October 1st. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Cantor Fitzgerald began coverage on National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price target on the stock. KeyCorp lifted their price target on National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday. Finally, Wells Fargo & Company increased their price objective on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, National Health Investors has a consensus rating of “Buy” and a consensus target price of $87.00.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.